Cytokine secretion depends on Galα(1,3)Gal expression in a pig-to-human whole blood model

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 6346-6353

  Sæthre, Marit ^a   Schneider, Mårten K J ^b   Lambris, John D ^c   Magotti, Paola ^c   Haraldsen, Guttorm ^a   Seebach, Jörg D ^d   Mollnes, Tom E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1,3 GALACTOSYLTRANSFERASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOTAXIN; GALACTOSYLTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; LEPIRUDIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; UNCLASSIFIED DRUG; COMPLEMENT COMPONENT C5A; CYTOKINE;

ANIMAL CELL; AORTA; ARTICLE; BLOOD; COMPLEMENT INHIBITION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL PIG; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; BLOOD CELL; CELL CULTURE; COCULTURE; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; SPECIES DIFFERENCE; SWINE; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AORTA; BLOOD CELLS; CELLS, CULTURED; COCULTURE TECHNIQUES; COMPLEMENT C5A; CYTOKINES; E-SELECTIN; ENDOTHELIAL CELLS; GALACTOSYLTRANSFERASES; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; SPECIES SPECIFICITY; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 44449143038     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.6346     Document Type: Article

References (61)

1. Galili, U., S. B. Shohet, E. Kobrin, C. L. Stults, and B. A. Macher. 1988. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J. Biol. Chem. 263: 17755-17762.
2. Oriol, R., Y. Ye, E. Koren, and D. K. Cooper. 1993. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 56: 1433-1442. (Pubitemid 24018801)
3. Cooper, D. K., A. H. Good, E. Koren, R. Oriol, A. J. Malcolm, R. M. Ippolito, F. A. Neethling, Y. Ye, E. Romano, and N. Zuhdi. 1993. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl. Immunol. 1: 198-205. (Pubitemid 2020157)
4. Dalmasso, A. P., G. M. Vercellotti, R. J. Fischel, R. M. Bolman, F. H. Bach, and J. L. Platt. 1992. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol. 140: 1157-1166.
5. McCurry, K. R., D. L. Kooyman, C. G. Alvarado, A. H. Cotterell, M. J. Martin, J. S. Logan, and J. L. Platt. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat. Med. 1: 423-427.
6. Cozzi, E., and D. J. White. 1995. The generation of transgenic pigs as potential organ donors for humans. Nat. Med. 1: 964-966.
7. Lai, L., D. Kolber-Simonds, K. W. Park, H. T. Cheong, J. L. Greenstein, G. S. Im, M. Samuel, A. Bonk, A. Rieke, B. N. Day, et al. 2002. Production of α-1,3- galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295: 1089-1092. (Pubitemid 34132242)
8. Phelps, C. J., C. Koike, T. D. Vaught, J. Boone, K. D. Wells, S. H. Chen, S. Ball, S. M. Specht, I. A. Polejaeva, J. A. Monahan, et al. 2003. Production of α 1,3-galactosyltransferase-deficient pigs. Science 299: 411-414. (Pubitemid 36123998)
9. Platt, J. L., S. S. Lin, and C. G. McGregor. 1998. Acute vascular rejection. Xenotransplantation 5: 169-175. (Pubitemid 28444962)
10. Rieben, R., and J. D. Seebach. 2005. Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. Trends Immunol. 26: 2-5. (Pubitemid 40051983)
11. Kuwaki, K., Y. L. Tseng, F. J. Dor, A. Shimizu, S. L. Houser, T. M. Sanderson, C. J. Lancos, D. D. Prabharasuth, J. Cheng, K. Moran, et al. 2005. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 11: 29-31. (Pubitemid 40215833)
12. Chen, G., H. Qian, T. Starzl, H. Sun, B. Garcia, X. Wang, Y. Wise, Y. Liu, Y. Xiang, L. Copeman, et al. 2005. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat. Med. 11: 1295-1298. (Pubitemid 41752909)
13. Cooper, D. K. 1998. Xenoantigens and xenoantibodies. Xenotransplantation 5: 6-17. (Pubitemid 28137823)
14. Chen, G., H. Sun, H. Yang, D. Kubelik, B. Garcia, Y. Luo, Y. Xiang, A. Qian, L. Copeman, W. Liu, et al. 2006. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 81: 273-283.
15. Zhong, R. 2007. Gal knockout and beyond. Am. J. Transplant. 7: 5-11.
16. Saethre, M., B. C. Baumann, M. Fung, J. D. Seebach, and T. E. Mollnes. 2007. Characterization of natural human anti-non-Gal antibodies and their effect on activation of porcine Gal-deficient endothelial cells. Transplantation 84: 244-250. (Pubitemid 47205759)
17. Marshall, S. E., and K. I. Welsh. 2001. The role of cytokine polymorphisms in rejection after solid organ transplantation. Genes Immun. 2: 297-303. (Pubitemid 33674240)
18. Dallman, M. J., and G. J. Clark. 1991. Cytokines and their receptors in transplantation. Curr. Opin. Immunol. 3: 729-734.
19. Hardstedt, M., C. P. Finnegan, N. Kirchhof, K. A. Hyland, M. Wijkstrom, M. P. Murtaugh, and B. J. Hering. 2005. Post-transplant upregulation of chemokine messenger RNA in non-human primate recipients of intraportal pig islet xenografts. Xenotransplantation 12: 293-302. (Pubitemid 40868331)
20. Candinas, D., S. Belliveau, N. Koyamada, T. Miyatake, P. Hechenleitner, W. Mark, F. H. Bach, and W. W. Hancock. 1996. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation 62: 1920-1927. (Pubitemid 27014563)
21. Larsen, C. G., A. O. Anderson, E. Appella, J. J. Oppenheim, and K. Matsushima. 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243: 1464-1466. (Pubitemid 19087128)
22. Cassatella, M. A. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16: 21-26.
23. Millan, M. T., C. Geczy, K. M. Stuhlmeier, D. J. Goodman, C. Ferran, and F. H. Bach. 1997. Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression. Transplantation 63: 421-429. (Pubitemid 27086036)
24. Baumann, B. C., M. K. Schneider, B. G. Lilienfeld, M. A. Antsiferova, D. M. Rhyner, R. J. Hawley, and J. D. Seebach. 2005. Endothelial cells derived from pigs lacking Gal α(1,3)Gal: no reduction of human leukocyte adhesion and natural killer cell cytotoxicity. Transplantation 79: 1067-1072.
25. He, Z., C. Ehrnfelt, M. Kumagai-Braesch, K. B. Islam, and J. Holgersson. 2004. Aberrant expression of α-Gal on primary human endothelium does not confer susceptibility to NK cell cytotoxicity or increased NK cell adhesion. Eur. J. Immunol. 34: 1185-1195. (Pubitemid 39255998)
26. Peterson, M. D., R. Jin, S. Hyduk, P. Duchesneau, M. I. Cybulsky, and T. K. Waddell. 2005. Monocyte adhesion to xenogeneic endothelium during laminar flow is dependent on α-Gal-mediated monocyte activation. J. Immunol. 174: 8072-8081. (Pubitemid 40806318)
27. Seebach, J. D., M. K. Schneider, C. A. Comrack, A. LeGuern, S. A. Kolb, P. A. Knolle, S. Germana, H. DerSimonian, C. LeGuern, and D. H. Sachs. 2001. Immortalized bone-marrow derived pig endothelial cells. Xenotransplantation 8: 48-61. (Pubitemid 32127075)
28. Baumann, B. C., P. Forte, R. J. Hawley, R. Rieben, M. K. Schneider, and J. D. Seebach. 2004. Lack of galactose-α-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J. Immunol. 172: 6460-6467. (Pubitemid 38621256)
29. Holten, E. 1979. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J. Clin. Microbiol. 9: 186-188. (Pubitemid 9123780)
30. Sahu, A., B. K. Kay, and J. D. Lambris. 1996. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J. Immunol. 157: 884-891. (Pubitemid 26231396)
31. Katragadda, M., P. Magotti, G. Sfyroera, and J. D. Lambris. 2006. Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. J. Med. Chem. 49: 4616-4622. (Pubitemid 44162688)
32. Mastellos, D., J. C. Papadimitriou, S. Franchini, P. A. Tsonis, and J. D. Lambris. 2001. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J. Immunol. 166: 2479-2486. (Pubitemid 32173484)
33. Lappegard, K. T., J. Riesenfeld, O. L. Brekke, G. Bergseth, J. D. Lambris, and T. E. Mollnes. 2005. Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production. Ann. Thorac. Surg. 79: 917-923. (Pubitemid 40288747)
34. Lai, L., D. Kolber-Simonds, K. W. Park, H. T. Cheong, J. L. Greenstein, G. S. Im, M. Samuel, A. Bonk, A. Rieke, B. N. Day, et al. 2002. Production of α-1,3- galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295: 1089-1092. (Pubitemid 34132242)
35. Phelps, C. J., C. Koike, T. D. Vaught, J. Boone, K. D. Wells, S. H. Chen, S. Ball, S. M. Specht, I. A. Polejaeva, J. A. Monahan, et al. 2003. Production of α1,3-galactosyltransferase-deficient pigs. Science 299: 411-414. (Pubitemid 36123998)
36. Tai, H. C., M. Ezzelarab, H. Hara, D. Ayares, and D. K. Cooper. 2007. Progress in xenotransplantation following the introduction of gene-knockout technology. Transpl. Int. 20: 107-117. (Pubitemid 46121988)
37. Cowan, P. J. 2007. Coagulation and the xenograft endothelium. Xenotransplantation 14: 7-12. (Pubitemid 46051366)
38. Tseng, Y. L., K. Kuwaki, F. J. Dor, A. Shimizu, S. Houser, Y. Hisashi, K. Yamada, S. C. Robson, M. Awwad, H. J. Schuurman, et al. 2005. α1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 80: 1493-1500. (Pubitemid 41803633)
39. Markiewski, M. M., B. Nilsson, K. N. Ekdahl, T. E. Mollnes, and J. D. Lambris. 2007. Complement and coagulation: strangers or partners in crime? Trends Immunol. 28: 184-192. (Pubitemid 46476881)
40. Mollnes, T. E., O. L. Brekke, M. Fung, H. Fure, D. Christiansen, G. Bergseth, V. Videm, K. T. Lappegard, J. Kohl, and J. D. Lambris. 2002. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100: 1869-1877.
41. Banz, Y., T. Cung, E. Y. Korchagina, N. V. Bovin, A. Haeberli, and R. Rieben. 2005. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood. Xenotransplantation 12: 434-443. (Pubitemid 41499801)
42. Baumann, B. C., P. Forte, R. J. Hawley, R. Rieben, M. K. Schneider, and J. D. Seebach. 2004. Lack of galactose-α-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J. Immunol. 172: 6460-6467. (Pubitemid 38621256)
43. Robinson, L. A., L. Tu, D. A. Steeber, O. Preis, J. L. Platt, and T. F. Tedder. 1998. The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: implications for xenotransplantation. J. Immunol. 161: 6931-6938. (Pubitemid 28562240)
44. Schneider, M. K., M. Strasser, U. O. Gilli, M. Kocher, R. Moser, and J. D. Seebach. 2002. Rolling adhesion of human NK cells to porcine endothelial cells mainly relies on CD49d-CD106 interactions. Transplantation 73: 789-796. (Pubitemid 34260579)
45. Baumann, B. C., P. Forte, R. J. Hawley, R. Rieben, M. K. Schneider, and J. D. Seebach. 2004. Lack of galactose-α-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J. Immunol. 172: 6460-6467. (Pubitemid 38621256)
46. Al-Mohanna, F., S. Saleh, R. S. Parhar, K. Khabar, and K. Collison. 2005. Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: the occult role of neutrophils in xenograft rejection revealed. J. Leukocyte Biol. 78: 51-61. (Pubitemid 40979943)
47. Goodman, D. J., A. M. Von, A. Willson, M. T. Millan, and F. H. Bach. 1996. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 61: 763-771. (Pubitemid 26097238)
48. Gilli, U. O., M. K. Schneider, P. Loetscher, and J. D. Seebach. 2005. Human polymorphonuclear neutrophils are recruited by porcine chemokines acting on CXC chemokine receptor 2, and platelet-activating factor. Transplantation 79: 1324-1331. (Pubitemid 40734794)
49. Deng, M. C., G. Plenz, C. Labarrere, C. Marboe, H. A. Baba, M. Erre, and S. Itescu. 2002. The role of IL6 cytokines in acute cardiac allograft rejection. Transpl. Immunol. 9: 115-120.
50. Matsumiya, G., S. R. Gundry, S. Nehlsen-Cannarella, O. R. Fagoaga, T. Morimoto, S. Arai, N. Fukushima, C. W. Zuppan, and L. L. Bailey. 1997. Serum interleukin-6 level after cardiac xenotransplantation in primates. Transplant. Proc. 29: 916-919. (Pubitemid 27126022)
51. Wang, H., M. E. DeVries, S. Deng, M. H. Khandaker, J. G. Pickering, L. H. Chow, B. Garcia, D. J. Kelvin, and R. Zhong. 2000. The axis of interleukin 12 and γ interferon regulates acute vascular xenogeneic rejection. Nat. Med. 6: 549-555. (Pubitemid 30305905)
52. Tanaka, K., S. Yamagami, and J. W. Streilein. 2005. Evidence that T-helper type 2 cell-derived cytokines and eosinophils contribute to acute rejection of orthotopic corneal xenografts in mice. Transplantation 79: 1317-1323. (Pubitemid 40734793)
53. Holan, V., J. Pindjakova, A. Zajicova, M. Krulova, B. Zelezna, P. Matousek, and P. Svoboda. 2005. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells. Xenotransplantation 12: 227-234. (Pubitemid 40524983)
54. Zhang, X. G., Y. Lu, B. Wang, H. Li, L. Yu, C. Liu, Z. Wu, and X. M. Liu. 2007. Cytokine production during the inhibition of acute vascular rejection in a concordant hamster-to-rat cardiac xenotransplantation model. Chin. Med. J. 120: 145-149. (Pubitemid 46584914)
55. Lorant, T., H. Krook, J. Wilton, M. Olausson, G. Tufveson, O. Korsgren, and C. Johnsson. 2003. Intragraft cytokine mRNA expression in rejecting and non-rejecting vascularized xenografts. Xenotransplantation 10: 311-324. (Pubitemid 36903771)
56. Saadi, S., T. Takahashi, R. A. Holzknecht, and J. L. Platt. 2004. Pathways to acute humoral rejection. Am. J. Pathol. 164: 1073-1080. (Pubitemid 38235488)
57. Solomon, M. F., W. A. Kuziel, D. A. Mann, and C. J. Simeonovic. 2003. The role of chemokines and their receptors in the rejection of pig islet tissue xenografts. Xenotransplantation 10: 164-177. (Pubitemid 36903786)
58. Lee, E. M., J. O. Park, D. Kim, J. Y. Kim, K. H. Oh, C. G. Park, B. H. Oh, S. Kim, and C. Ahn. 2006. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts. Xenotransplantation 13: 328-336. (Pubitemid 43882176)
59. Kim, J. Y., D. Kim, E. M. Lee, I. Choi, C. G. Park, K. S. Kim, J. Ha, S. J. Kim, J. Yang, Y. S. Kim, et al. 2003. Inducible nitric oxide synthase inhibitors prolonged the survival of skin xenografts through selective down-regulation of pro-inflammatory cytokine and CC-chemokine expressions. Transpl. Immunol. 12: 63-72. (Pubitemid 37321506)
60. Nykanen, A. I., R. Krebs, J. M. Tikkanen, O. Raisky, R. Sihvola, J. Wood, P. K. Koskinen, and K. B. Lemstrom. 2005. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Transplantation 79: 182-189.
61. Tambur, A. R., S. Pamboukian, M. R. Costanzo, and A. Heroux. 2006. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. J. Heart Lung Transplant. 25: 690-698. (Pubitemid 43766575)